Skip Navigation

Cardiovascular Research 1999 44(3):536-542; doi:10.1016/S0008-6363(99)00227-8
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Piot, C. A
Right arrow Articles by Wolfe, C. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piot, C. A
Right arrow Articles by Wolfe, C. L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo

Christophe A Piota,*, Jean-François Martinib, Steve K Buia and Christopher L Wolfea

aCardiovascular Research Institute, Department of Medicine (Cardiology Division), University of California, San Francisco, CA, USA
bReproductive Endocrinology Center, University of California, San Francisco, CA, USA

* Corresponding author. Service de Cardiologie B, Hôpital Arnaud de Villeneuve, 371, av Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Tel.: +33-046-733-6187; fax: +33-046-733-6186 c-piot{at}chu-montpellier.fr

Recently, we have demonstrated that ischemic preconditioning (IP) both limits infarct size and decreases internucleosomal DNA fragmentation in rat hearts in vivo, and that there was a direct correlation between myocardial infarct size and DNA fragmentation even after IP. In this study, we examined the ability of IP to attenuate processing and activation of caspase-1 and caspase-3, and cleavage of poly(ADP-ribose) polymerase (PARP), after prolonged ischemia and reperfusion using the same in vivo animal model. Rats that underwent IP and controls (Ctrl) were subjected to 30 min of left coronary artery occlusion followed by 180 min of reperfusion. IP was accomplished by five 5-min cycles of ischemia, each followed by 5 min of reperfusion. The amount of soluble nucleosomes was measured by enzyme-linked immunosorbent assay. Cleavage of caspases-1 and -3, and of one of their substrates PARP, was analyzed by Western blotting. Nucleosomal DNA fragmentation was significantly reduced in ischemic left ventricular (LV) tissue obtained from IP compared with Ctrl animals. The proforms of caspases-1 and -3, and the active form of PARP were not cleaved in the nonischemic LV region of both IP and Ctrl hearts. In contrast, the proform of caspase-3 and the active form of PARP were cleaved in the ischemic LV region of Ctrl hearts, while processing of caspase-1 was increased. Cleavages of caspases-1 and -3, and inactivation of PARP were prevented by IP. The results of this study indicate that IP attenuates both internucleosomal DNA fragmentation and caspases processing, and suggest that the prevention of caspases activation by IP may be important steps in protecting the heart against ischemia/reperfusion injury in vivo.

KEYWORDS Apoptosis; Ischemia; Reperfusion; Preconditioning


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Pavoine and F. Pecker
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Cardiovasc Res, May 1, 2009; 82(2): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Zhang, T. S. Park, and J. M. Gidday
Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2573 - H2581.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Boodhwani, J. Feng, S. Mieno, B. Ramlawi, N. Sodha, R. Clements, and F. W. Sellke
Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Syed, H. S. Hahn, A. Odley, Y. Guo, J. G. Vallejo, R. A. Lynch, D. L. Mann, R. Bolli, and G. W. Dorn II
Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia
Circ. Res., May 27, 2005; 96(10): 1103 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Okubo, Y. Tanabe, K. Takeda, M. Kitayama, S. Kanemitsu, R. C. Kukreja, and N. Takekoshi
Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of {delta}-opioid receptor
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1786 - H1791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Argaud, A.-F. Prigent, L. Chalabreysse, J. Loufouat, M. Lagarde, and M. Ovize
Ceramide in the antiapoptotic effect of ischemic preconditioning
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H246 - H251.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Z.-K. Wu, J. Laurikka, A. Saraste, V. Kyto, E. J. Pehkonen, T. Savunen, and M. R. Tarkka
Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations
Ann. Thorac. Surg., August 1, 2003; 76(2): 528 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P A J Krijnen, R Nijmeijer, C J L M Meijer, C A Visser, C E Hack, and H W M Niessen
Apoptosis in myocardial ischaemia and infarction
J. Clin. Pathol., November 1, 2002; 55(11): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Zhang, D. M. Rosenbaum, A. R. Shaikh, Q. Li, P. S. Rosenbaum, D. J. Pelham, and S. Roth
Ischemic Preconditioning Attenuates Apoptotic Cell Death in the Rat Retina
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3059 - 3066.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z.-Q. Zhao and J. Vinten-Johansen
Myocardial apoptosis and ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 438 - 455.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C A Dinarello
Novel targets for interleukin 18 binding protein
Ann Rheum Dis, November 1, 2001; 60(90003): iii18 - 24.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. J. Pomerantz, L. L. Reznikov, A. H. Harken, and C. A. Dinarello
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta
PNAS, February 27, 2001; 98(5): 2871 - 2876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Xu, Y. Wang, K. Hirai, A. Ayub, and M. Ashraf
Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H899 - H908.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. O'Rourke
Myocardial KATP Channels in Preconditioning
Circ. Res., November 10, 2000; 87(10): 845 - 855.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.